Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors. (9th January 2019)

Record Type:: Journal Article
Title:: Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors. (9th January 2019)
Main Title:: Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
Authors:: Soria, J -C
Cortes, J
Massard, C
Armand, J -P
De Andreis, D
Ropert, S
Lopez, E
Catteau, A
James, J
Marier, J -F
Beliveau, M
Martell, R E
Baselga, J
Abstract:
Is Part Of:: Annals of oncology. Volume 30:Number 6(2019)
Journal:: Annals of oncology
Issue:: Volume 30:Number 6(2019)
Issue Display:: Volume 30, Issue 6 (2019)
Year:: 2019
Volume:: 30
Issue:: 6
Issue Sort Value:: 2019-0030-0006-0000
Page Start:: 1020
Page End:: 1020
Publication Date:: 2019-01-09
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy532 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 11794.xml